4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-25-000004
Chief Business Officer sold 15,936 shares at $11.20 ($178,501)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hull Hans Chief Business Officer | 2025-01-17 | Sale 10b5-1 | −15,936 | $11.20 | $178,501 | 211,558 | D |
| Open-market sales · 15,936 sh · avg $11.20 · $178,501 | |||||||
Loading xslF345X05/wk-form4_1737586946.xml…